Axa S.A. Bio Techne Corp Transaction History

Axa S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $726,030 - $3.17 Million	9,000 Added 596.82%	10,508 $870,000
Q3 2022 Feb 14, 2023	BUY	$282.54 - $391.85 $170,089 - $235,893	602 Added 66.45%	1,508 $428,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $426,070 - $590,909	1,508 New	1,508 $428,000
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $292,339 - $407,382	-906 Closed	0 $0
Q1 2022 Feb 14, 2023	SELL	$353.85 - $487.79 $213,017 - $293,649	-602 Reduced 39.92%	906 $392,000
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $35,385 - $48,779	100 Added 12.41%	906 $392,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $22,807 - $26,252	-50 Reduced 5.84%	806 $417,000
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $8,007 - $9,699	18 Added 2.15%	856 $415,000
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $132,473 - $153,988	-342 Reduced 28.98%	838 $377,000
Q1 2021 May 14, 2021	SELL	$314.62 - $411.0 $13,528 - $17,673	-43 Reduced 3.52%	1,180 $451,000
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $136,288 - $177,672	-552 Reduced 31.1%	1,223 $388,000
Q3 2020 Nov 13, 2020	BUY	$232.22 - $282.96 $10,449 - $12,733	45 Added 2.6%	1,775 $440,000
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $320,793 - $483,638	1,730 New	1,730 $457,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.